Collapsing Glomerulopathy in Identical Twins With Lupus and High-Risk Apolipoprotein L1 (APOL1) Genotype.
Collapsing Glomerulopathy in Identical Twins With Lupus and High-Risk Apolipoprotein L1 (APOL1) Genotype.
复制标题
DOI:
10.1016/j.ekir.2021.06.005
复制
发表时间:
2021-09
影响因子:
6
通讯作者:
Sparks MA
中科院分区:
文献类型:
--
作者:
DeOliveira M;Feeney C;Leahy C;Nystrom S;Howell DN;Farouk SS;Wu M;Olabisi OA;Sparks MA
Collapsing glomerulopathy (CG) is characterized by global or segmental collapse of the glomerular capillary tuft along with proliferation of overlying parietal epithelial cells. It is associated with multiple etiologies including human immunodeficiency virus (HIV), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), autoimmune diseases including systemic lupus erythematosus (SLE), malignancy, drug exposures, and other viral illnesses. 1 Patients usually present acutely with severe acute kidney injury (AKI) and proteinuria. Irrespective of the etiology, CG is a marker of poor prognosis. It is predominantly seen in individuals of recent West African ancestry. Cumulative evidence demonstrates that carriage of 2 apolipoprotein L1 (APOL1) kidney risk variants (KRVs) increases the risk of CG in SLE, 2 HIV, 3 transplanted donor kidneys, 4, 5 and SARS-CoV-2. 6 However, not all carriers of 2 APOL1 KRVs develop CG. Attempts to explain this apparent incomplete penetrance gave rise to the “2-hit hypothesis” that proposes that a second hit—either environmental trigger or additional genetic factors other than 2 APOL1 KRVs—is necessary for pathogenesis of APOL1-associated CG. Because CG is associated with diseases with high inflammatory cytokines, and as iatrogenic interferons have been associated with CG, 7, 8, 9 it has been speculated that environmental factors or conditions such as SLE, which raise levels of circulating interferons, would constitute second hits. However, combination of 2 APOL1 KRVs and known second hits such as HIV or SLE results in APOL1-associated kidney disease (AAKD) in only a fraction of all cases, raising the possibility that the additional genetic or epigenetic modifiers are essential for onset or progression of AAKD. Genome-wide association studies of heterogenous patient population did not reveal reproducible common genetic modifier of AAKD. S1 The failure of these genome-wide association studies is likely driven by multiple factors including the possibility of insufficient power to detect polygenic risk modifiers with modest effect sizes in heterogenous population. Here, we present 2 cases of identical twins with a history of SLE who developed APOL1-associated CG. We propose that this twin-case adds evidence in support of the possible role of a patient’s genetic background in the pathogenesis of APOL1-associated CG and that the identical genome of monozygotic twins with APOL1-associated CG may be ideal for discovering such genetic modifiers of AAKD.
登录
查看更多内容
影响因子:
19.6
作者:
通讯作者:
--
影响因子:
8.8
作者:
Shah, P. B.;Cooper, J. E.;Wiseman, A. C.
通讯作者:
Wiseman, A. C.
影响因子:
13.6
作者:
Kopp, Jeffrey B.;Nelson, George W.;Winkler, Cheryl A.
通讯作者:
Winkler, Cheryl A.
DOI:
10.2215/cjn.07311009
发表时间:
2010-04-01
影响因子:
9.8
作者:
Markowitz, Glen S.;Nasr, Samih H.;D'Agati, Vivette D.
通讯作者:
D'Agati, Vivette D.
影响因子:
13.6
作者:
Wu, Huijuan;Larsen, Christopher P.;Velez, Juan Carlos Q.
通讯作者:
Velez, Juan Carlos Q.